8.1.6.4Vertical

Life Sciences & Research Properties

Lab and research campus properties for biotech tenants.

Market snapshot

These figures describe Office Buildings & Corporate Campuses (8.1.6), the segment that Life Sciences & Research Properties sits within — not Life Sciences & Research Properties on its own.

FragmentationFragmentedEstimate

Office leasing sits within nonresidential building lessors (NAICS 531120) and is not separately disclosed by the Census Bureau, so the segment is not separately sized here.

Business model & economics

Revenue model

Office lease income

Key economics

Recurring revenue
Moderate

leases, but elevated vacancy risk

EBITDA margin
Pressured

rising vacancy and concessions

Capex intensity
High

Characteristics

  • Most distressed CRE sector (remote/hybrid work).
  • Trophy office leases; commodity office obsolescing.
  • Refinancing crisis and painful repricing.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Distressed & opportunistic investors
  • Conversion developers (office-to-residential)
  • Trophy-asset owners & REITs

What’s driving deals

  • Distress, repricing, and refinancing maturities.
  • Office-to-residential conversions.
  • Flight to quality and trophy assets.

Find Life Sciences & Research Properties acquisition targets

Search Acquisera’s index for companies classified under Life Sciences & Research Properties (8.1.6.4) and build a targeted deal pipeline.

Search companies